By
Orthopedic Braces and The global orthopedic braces and supports market is projected to reach USD 5.92 billion by 2030, rising from an estimated USD 4.32 billion in 2025 at a compound annual growth rate of 6.5%, according to a market brief on the sector.
For prosthetic and orthotic clinicians, technicians, rehabilitation providers and suppliers across the IMEA region, the forecast highlights a market that is moving beyond conventional immobilisation and into a more dynamic, patient-centred category of orthotic care.
Orthopedic braces and supports include a wide range of products used in injury management, post-operative protection, ligament support, joint stabilisation, chronic musculoskeletal conditions, sports medicine, ageing-related mobility support and rehabilitation. The sector overlaps directly with clinical orthotics, retail medical supply, physiotherapy, sports medicine and hospital-based rehabilitation.
North America Remains the Dominant Market
The report indicates that North America held the largest market share in 2024, accounting for 47.6% of total revenue. This reflects the region’s strong reimbursement systems, high sports medicine utilisation, extensive retail distribution, established orthopaedic device companies and high patient awareness.
For IMEA markets, the North American share is important because many global product standards, marketing models and distribution strategies continue to be shaped by US-based and European suppliers. However, growth opportunities in the Middle East, Africa and South Asia are likely to depend on different drivers, including affordability, local clinical capacity, public procurement, access to rehabilitation services and the availability of trained orthotists and technicians.
The wider need for assistive products remains significant. The World Health Organization reports that more than 2.5 billion people globally need one or more assistive products, and that demand could rise to 3.5 billion by 2050. Bracing and mobility-related supports form part of this wider assistive technology ecosystem, especially for people with injury, disability, ageing-related mobility limitations, long-term conditions and musculoskeletal disorders.
Knee Braces Lead Product Growth
Among product categories, knee braces and supports are projected to record the highest growth, with a forecast CAGR of 7.8% through 2030.
This is clinically significant for O&P providers because knee bracing is one of the most common interfaces between orthotic practice, sports injury management, post-operative care and retail orthopaedic supply. Demand is being driven by ligament injuries, osteoarthritis, meniscal problems, sports participation, obesity-related joint stress and post-surgical rehabilitation.
For CPOs and rehabilitation teams, the growth of knee bracing also raises questions about prescription quality. A brace supplied through a pharmacy or retailer may meet basic support needs, but more complex cases still require clinical assessment, alignment knowledge, fitting skill and follow-up. This is particularly true for functional knee braces, osteoarthritis unloading braces, paediatric cases, neurological presentations and patients with multiple mobility limitations.
LCL Injury Segment Shows Fastest Application Growth
The market brief identifies the lateral collateral ligament injury segment as the fastest-growing application, with an expected CAGR of 9.0% during the forecast period.
Although anterior cruciate ligament injuries often receive the most public attention, lateral collateral ligament injuries can require careful bracing decisions, especially when combined with posterolateral corner instability or multi-ligament knee trauma. For clinicians, this reinforces the need for high-quality knee assessment, accurate diagnosis, correct brace selection and patient education.
In many IMEA settings, ligament bracing may be influenced by limited access to sports medicine specialists, imaging, insurance coverage or follow-up physiotherapy. This creates both a clinical challenge and a service opportunity for orthotic providers who can support hospitals, orthopaedic surgeons and rehabilitation teams with structured bracing pathways.
Pharmacies and Retailers Expand Their Role
The pharmacies and retailers segment is expected to lead the market and record the highest CAGR of 7.0% from 2025 to 2030.
This trend reflects a broader shift in orthopedic supports from specialist-only channels into retail, pharmacy, e-commerce and direct-to-consumer pathways. For simple elastic supports, ankle braces, wrist splints and basic knee sleeves, this may improve access and convenience. However, it also increases the risk that patients may self-select products that are unsuitable for their condition.
For the O&P profession, this is not only a competitive issue. It is also a patient-safety and quality-of-care issue. Braces that are poorly fitted, incorrectly indicated or used without guidance may fail to control motion, create pressure problems, delay proper diagnosis or give patients a false sense of security.
Clinics and suppliers in the IMEA region may need to respond by building stronger referral pathways with pharmacies, sports medicine centres, orthopaedic surgeons, physiotherapists and hospitals. There is also an opportunity for professional education, product training and tiered bracing models that distinguish between off-the-shelf supports and clinically fitted orthoses.
Smart Bracing and Digital Orthotic Systems
One of the most important shifts identified in the market brief is the transition from conventional immobilisation toward dynamic, patient-centric bracing systems that may integrate smart sensors, IoT connectivity and AI-driven motion analysis.
This shift aligns with wider innovation across assistive technology, where digital tools, sensors, connected devices and data-driven systems are increasingly used to monitor function, improve adherence and support rehabilitation planning.
For orthopedic bracing, smart technologies could support:
- Real-time movement monitoring
- Range-of-motion tracking
- Load and activity measurement
- Post-operative compliance monitoring
- Remote rehabilitation feedback
- AI-assisted gait and motion analysis
- Better patient education and engagement
However, smart bracing also brings challenges. Devices must be affordable, durable, clinically validated and practical in real-world service settings. In many IMEA markets, connectivity, maintenance, reimbursement and clinician training will be just as important as the technology itself.
Leading Industry Players
The market brief highlights several major companies with strong positions in the orthopedic braces and supports sector, including 3M Company, DJO LLC / Enovis, and Essity Health & Medical.
Other prominent global names in bracing and orthopedic supports include Össur, Thuasne, Ottobock, Bauerfeind, Breg, Medi, Zimmer Biomet, DeRoyal, Alcare and Nippon Sigmax.
The presence of large multinational companies reflects the maturity of the category, but local distribution, clinical training and after-sales support remain key differentiators in emerging and cost-sensitive markets.
What This Means for IMEA CPOs and Suppliers
For the IMEA region, growth in the orthopedic braces and supports market should be seen through a practical service-delivery lens.
The opportunity is not simply to sell more braces. The opportunity is to improve bracing outcomes through better assessment, prescription, fitting, patient education and follow-up.
Key implications for IMEA stakeholders include:
- Orthotic clinics should strengthen clinical bracing protocols for knee, ankle, wrist, spine and post-operative supports.
- Technicians should maintain fitting, modification and adjustment skills for both off-the-shelf and custom bracing systems.
- Suppliers should invest in clinician education, not only product catalogues.
- Hospitals and rehabilitation centres should develop clearer pathways for post-operative and injury-related bracing.
- Governments and insurers should recognise appropriate bracing as part of rehabilitation and assistive technology access.
- NGOs and humanitarian providers should consider braces and supports as important tools for trauma rehabilitation, mobility restoration and prevention of secondary complications.
The WHO has emphasised that assistive technology access depends not only on products but also on provision systems, policy, trained personnel and affordability. That principle applies directly to orthopedic braces and supports.
Market Growth Must Be Matched by Professional Standards
The forecasted growth to USD 5.92 billion by 2030 shows that orthopedic bracing is becoming a larger and more technologically advanced segment of the global rehabilitation and assistive technology market.
For CPOs, the message is clear: bracing remains a core part of orthotic practice, even as retail channels expand and smart technologies enter the market. The profession has an important role to play in ensuring that braces are not treated as generic consumer products when clinical assessment and fitting expertise are required.
As the market grows, IMEA CPO will continue to monitor how global suppliers, digital platforms, reimbursement systems and regional service providers shape the next phase of orthopedic bracing across the Middle East, Africa and India-adjacent markets.
